Copernicus Group IRB approval

Surviving Mold is delighted to announce that one of its credentialed physicians, Dr. Scott McMahon of Roswell, New Mexico, has been credentialed as a Principal Investigator by Copernicus Group IRB of Research Triangle Park, NC!

The credentialing process was involved, with a need to obtain NIH approval of his investigator status as well as developing research protocols and study designs that are deemed to be acceptable science by a human ethics research board. Compare this approval of Dr. McMahon with some papers recently published in the mold community that have no IRB approval at all.

Dr. McMahon has begun work on his project that involves use of NeuroQuant testing to use brain injury measurements to separate mold from control patients; and Lyme from control and mold patients.

Dr. McMahon was assisted in this quest by Dr. Ritchie Shoemaker who has obtained IRB approval for 13 separate research projects.

Featured Resources

Shoemaker Protocol™ Quick Start:

The 3 initial steps to determine if mold is affecting you One of the most common questions we hear is, “how do I know if I have mold illness?” Rest assured, if you’re asking this question, you’ve come to the right place.

Better than Resolutions

Every year when the New Year rolls around, people begin to make goals and resolutions to be more health-focused, especially after a busy, festive holiday season.

No luck finding a Shoemaker Certified Practitioner? Here are some solutions:

The top inquiries to our site continue to be, ‘”Is there a Shoemaker Certified Practitioner near me? And, “Is there one who also takes my insurance?” While we don’t have practitioners in every region as of yet, many certified practitioners are set...

Online Proficiency Partners Course

Join a life-changing team helping patients with CIRS recover and thrive.

Lyme Biomarkers Publication Now Available!

Illnesses characterized by chronic fatigue are often defined by symptoms and not by objective biomarkers that support both diagnosis and treatment. Without readily obtained biomarkers, clinical management can be compromised by lack of certainty. This uncert...